LifeSci Advisors Continues Expansion of U.S. Team with Appointment of Daniel Ferry
NEW YORK, Nov. 07, 2017 (GLOBE NEWSWIRE) -- LifeSci Advisors, LLC (the "Company" or "LifeSci"), the leading international investor relations and corporate communications firm dedicated to the life sciences sector, today announced the appointment of Daniel Ferry as Managing Director. Mr. Ferry will serve as a Relationship Manager and will contribute to Corporate Access. He will be based out of LifeSci's Boston office.
Mr. Ferry joins LifeSci Advisors from Guggenheim Securities, where he served as a Director in the Boston office. At Guggenheim, Daniel worked across multiple industries but specialized in connecting healthcare companies with buy-side investors, venture capitalists, key opinion leaders, sell-side analysts, and the firm's investment bank. In his four years at Guggenheim Securities, he organized numerous non-deal roadshows, collected feedback from investors, and helped shape investor outreach strategies. Prior to joining Guggenheim, Daniel worked at Lazard Capital Markets, where he grew middle markets revenue by over 400% and participated in many successful healthcare company financings. He began his career with Fidelity Investments. Over the course of his twenty-year career in financial services, Daniel has developed long-standing relationships with the healthcare investment community. He received a BS in Finance from the University of Southern California. He also holds Series 7 and Series 63 licenses.
Passionate about the rights of people with disabilities, Daniel is active in a number of nonprofit organizations, including Newton Athletes Unlimited and the Massachusetts Down Syndrome Congress, for whom he ran the Boston Marathon in 2011. Daniel currently resides with his wife, Norah, and their three children, Gwen, Charlie, and Willa, in Newton, Massachusetts.
"We are pleased to add Daniel to our growing team," said Andrew McDonald, CEO and Founding Partner of LifeSci Advisors. "While serving as Director of Equity Sales at Guggenheim, Daniel ensured his life science clients were meeting with the right investors across the globe. With more than 20 years of experience in the healthcare banking business, Daniel is well-connected within the healthcare investment community. As a growing international investor and corporate communications firm, we continue to attract top talent, like Daniel, to provide counsel and support our client companies. We look forward to leveraging Daniel's expertise and expansive network of investor contacts."
"I am excited to be a part of the largest and growing life sciences investor relations firm," said Mr. Ferry. "LifeSci has established itself as a leader in the healthcare industry, both among companies and within the investment community. I look forward to a successful and rewarding career as a member of the LifeSci team."
LifeSci has offices in Israel, UK and Switzerland, as well as multiple North American locations. The firm's capabilities include Corporate Access, Equity Research, Corporate Communications, KOL Events, Corporate Governance, Capital Markets Solutions, and Public Relations.
LifeSci Advisors, LLC (www.lifesciadvisors.com) is the largest investor relations consultancy in the life sciences industry, founded to provide companies with a multi-faceted approach to investor communications and outreach. With a global focus and reach, the firm provides the highest quality service for its clients through its deep sector specialization. LifeSci's team of MDs and PhDs enables the firm to better understand clients' R&D, regulatory and commercial strategies, and its team of financial services, investor relations and public relations specialists helps clients effectively communicate to the marketplace. This combination of life sciences, financial services, and investor relations competencies allows LifeSci Advisors to provide an invaluable and unique service offering to clients.
LifeSci Partners (www.lifescipartners.com) is the leading provider of consulting services in the areas of investor relations, public relations, corporate communications and capital markets advisory. Combining deep domain expertise in the life sciences with decades of experience in capital markets and public relations, LifeSci Partners delivers unparalleled services to life sciences companies globally.
For further information, please contact:
CEO, Founding Partner
LifeSci Advisors, LLC
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: LifeSci Advisors, LLC via Globenewswire
Om Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York
+1 212 401 8700http://www.nasdaqomx.com
NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra Nasdaq GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Nasdaq GlobeNewswire
2018 European Cost Insight Product Cost Management Conference17.10.2018 10:00 | Pressemelding
Companies from Across Europe to Gather and Discuss How PCM Strategies & Technologies Improve Profitability & Accelerate Design to Delivery Time CONCORD, Mass., Oct. 17, 2018 (GLOBE NEWSWIRE) -- aPriori, the leading provider of enterprise product cost management (PCM) software solutions, announces today that it will host the European Cost Insight Product Cost Management Conference on November 26-28, 2018. This year’s event is being held at Hilton Amsterdam Airport Schiphol in Amsterdam, The Netherlands. This event is open to both aPriori customers and representatives from any manufacturers that are interested in learning more about product cost management technology and best practices. Visit the Cost Insight 2018 Event Website for complete information and register for this year’s program. Why Should You Attend Cost Insight 2018? As pressure increases to deliver innovative and customized products to market faster, manufacturers are struggling to maintain product profits and accelerate de
In-Memory Computing Summit North America 2018 Lays Out Vision for Digital Technology Evolution, Provides Practical Advice for Addressing Performance and Scalability Challenges17.10.2018 09:00 | Pressemelding
Keynotes, Breakout Sessions from Industry Leaders and Technology Experts Offer Actionable Advice on Navigating the Trends, Challenges and Solutions of Digital Transformation FOSTER CITY, Calif., Oct. 17, 2018 (GLOBE NEWSWIRE) -- GridGain® Systems, provider of enterprise-grade in-memory computing solutions based on Apache® Ignite™, today discussed the success of the fourth annual In-Memory Computing Summit® North America, which took place October 2-3, 2018 at the Hyatt Regency San Francisco Airport. The In-Memory Computing Summits (IMCSs), held annually in Europe and North America, are the only industry-wide events focusing on the full range of in-memory computing technologies and solutions. Nearly 450 people representing 227 organizations from 10 countries across 4 continents and 19 U.S. states registered to listen to speakers from American Airlines, ING Belgium, Intel Corp., Oracle, Salesforce.com, Huawei, SNIA, Wellington Management, GridGain Systems and many more. Recordings and sli
IMRALDI™, Biogen’s Adalimumab Biosimilar Referencing Humira®, Is Launched in the European Union17.10.2018 08:00 | Pressemelding
IMRALDITM is approved in the European Union for the same 14 complex autoimmune conditions as its reference product In 2017 Biogen became the first company in Europe with approved biosimilars referencing the three most prescribed anti-TNF biologic treatments BAAR, Switzerland, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Samsung Bioepis Co. Ltd, a joint venture between Samsung BioLogics and Biogen (Nasdaq: BIIB) today announced the European launch of IMRALDITM, an adalimumab biosimilar referencing Humira®.1 IMRALDI is approved in Europe for the treatment of rheumatoid arthritis (RA), juvenile idiopathic arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis, paediatric plaque psoriasis, adult and adolescent hidradenitis suppurativa, Crohn’s disease, paediatric Crohn’s disease, ulcerative colitis and uveitis. The launch of IMRALDI completes Biogen’s portfolio of three anti-TNF biosimilars in Europe, with BENEPALITM (etanercept), a biosimilar referencing Enbrel® 2, and FLIXABITM (inflixi
Atico Produces 5.36 Million Pounds of Cu and 3,010 Ounces of Au in Third Quarter 201816.10.2018 22:30 | Pressemelding
VANCOUVER, British Columbia, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC: ATCMF) announces its operating results for the three months ended September 30, 2018 from its El Roble mine. Production for the quarter totaled 5.36 million pounds of copper and 3,010 ounces of gold in concentrates, an increase of 5% for copper and 6% for gold, respectively, over the same period in 2017. “We are pleased to report another strong quarter of production as the El Roble mine continues to operate at a steady state level while the Company remains on track to deliver on our 2018 operational objectives,” said Fernando E. Ganoza, CEO. “For remainder of the year, we will continue optimizing the operation and executing the aggressive exploration drilling program at the El Roble property looking for additional mineralization both regionally and at mine vicinity.” Third Quarter Operational Highlights Production of 5.36 million pounds of copper contain
SoftServe’s Research Team Takes Prize at Samsung AI Challenge16.10.2018 21:16 | Pressemelding
Artificial intelligence leveraged to deblur and dehaze photos and videos with exceptional quality AUSTIN, Texas, Oct. 16, 2018 (GLOBE NEWSWIRE) -- SoftServe, a leading digital authority and consulting company, announced its researchers won second place at the Samsung AI Challenge 2018 with innovative neural image restoration enhancement for mobile and embedded devices. “Artificial intelligence is at the center of future-proofing technologies for many businesses today,” said Serge Haziyev, senior vice president for Advanced Technology at SoftServe. “The opportunities for AI are endless and we are proud of our team and their commitment to creating an innovative AI algorithm that pushed the boundaries of existing deblurring and dehazing technologies as part of Samsung’s AI Hackathon.” The winning team, made up of SoftServe research engineers, Volodymyr Budzan and Orest Kupyn, participated in the worldwide event developing a solution that uses state-of-the-art deep learning and computer vi
IRYStec Selected as CIX Top 20 Innovator for 2018!16.10.2018 17:52 | Pressemelding
MONTREAL, Oct. 16, 2018 (GLOBE NEWSWIRE) -- IRYStec Software Inc., today announced it was selected as one of the CIX Top 20 most innovative companies of 2018 in Canada. Chosen from hundreds of profiles by industry experts and investors, the winner will represent Canada at the Start-up World Cup Grand Finale In 2019! The CIX Top 20 program is Canada’s largest national showcase of the 20 hottest and most innovative tech companies. Hundreds of applications are submitted each year from across Canada and the CIX Selection Committee evaluates and selects 20 based on 5 criteria: Business Model, Quality of Product and Service Offering, Innovation, Market Opportunity and Depth of Management. CTO and Co-founder, Tara Akhavan, will be presenting at CIX 2018 on Oct 23 at 1 PM. Both Tara and Simon Morris, CEO, will be attending both days demonstrating why all displays in the near future will be perceptual displays driven by IRYStec’s Perceptual Display Platform technology. A crowd of over 800 inves
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom